This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Akorn Inc (AKRX)

NASDAQ: Health Care

Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 593.08M 317.71M 256.16M 136.92M
Cost of Sales 248.02M 141.50M 102.73M 51.77M
Gross Operating Profit 345.06M 176.21M 153.42M 85.15M
Selling, General, and Administrative Expenses 95.46M 53.51M 48.05M 33.13M
Research & Development 29.20M 19.86M 15.86M 11.55M
Operating Income before D & A (EBITDA) 220.40M 102.84M 89.51M 40.46M
Depreciation & Amortization 91.54M 12.57M 11.60M 7.19M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -1.92M 4.10M -782.00K -2.12M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 94.79M 91.54M 67.97M 45.70M
Interest Expense 35.66M 8.65M 10.47M 4.39M
Pre-Tax Income 59.14M 82.89M 57.50M 41.31M
Income Taxes 23.29M 30.53M 22.12M -1.71M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 35.85M 52.36M 35.38M 43.01M
Net Income From Discontinued Operations -503.00K 0.00 0.00 0.00
Net Income From Total Operations 35.34M 52.36M 35.38M 43.01M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 35.34M 52.36M 35.38M 43.01M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
68.00M 55.27M 44.53M 43.01M
Preferred Dividends
Net Income Available To Common 35.85M 52.36M 35.38M 43.01M
Basic EPS from Continuing Ops. 0.35 0.54 0.37 0.45
Basic EPS from Discontinued Ops. -0.01 0.00 0.00 0.00
Basic EPS from Total Operations 0.34 0.54 0.37 0.45
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.34 0.54 0.37 0.45
Basic Normalized Net Income/Share 0.66 0.57 0.47 0.45
EPS fr Continuing Ops. 0.34 0.46 0.32 0.41
EPS fr Discontinued Ops -0.01 0.00 0.00 0.00
EPS fr Total Ops. 0.33 0.46 0.32 0.41
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.33 0.46 0.32 0.41
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.64 0.49 0.40 0.41
Dividends Paid per Share 0.00 0.00 0.00 0.00
AKRX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for AKRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 7 7 7 7
Moderate Buy 1 1 1 1
Hold 5 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET AKRX ANALYST REPORT

AKRX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs